AU2003300656A1 - Novel angiogenic molecular target and uses thereof - Google Patents

Novel angiogenic molecular target and uses thereof

Info

Publication number
AU2003300656A1
AU2003300656A1 AU2003300656A AU2003300656A AU2003300656A1 AU 2003300656 A1 AU2003300656 A1 AU 2003300656A1 AU 2003300656 A AU2003300656 A AU 2003300656A AU 2003300656 A AU2003300656 A AU 2003300656A AU 2003300656 A1 AU2003300656 A1 AU 2003300656A1
Authority
AU
Australia
Prior art keywords
molecular target
novel angiogenic
angiogenic molecular
novel
target
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003300656A
Other versions
AU2003300656A8 (en
Inventor
Silvere Petit
Fabien Schweighoffer
Emmanuel Valentin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ExonHit Therapeutics SA
Original Assignee
ExonHit Therapeutics SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ExonHit Therapeutics SA filed Critical ExonHit Therapeutics SA
Publication of AU2003300656A1 publication Critical patent/AU2003300656A1/en
Publication of AU2003300656A8 publication Critical patent/AU2003300656A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90—Isomerases (5.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biotechnology (AREA)
  • Rheumatology (AREA)
  • Microbiology (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003300656A 2002-12-18 2003-12-17 Novel angiogenic molecular target and uses thereof Abandoned AU2003300656A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0216123A FR2849055A1 (en) 2002-12-18 2002-12-18 Using inhibitors of protein FKBP65 for treating cancer and other diseases where angiogenesis is involved, also new isoforms of FKBP65, related nucleic acids and diagnostic uses
FR02/16123 2002-12-18
PCT/FR2003/003776 WO2004056991A2 (en) 2002-12-18 2003-12-17 Novel angiogenic molecular target and uses thereof

Publications (2)

Publication Number Publication Date
AU2003300656A1 true AU2003300656A1 (en) 2004-07-14
AU2003300656A8 AU2003300656A8 (en) 2004-07-14

Family

ID=32406174

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003300656A Abandoned AU2003300656A1 (en) 2002-12-18 2003-12-17 Novel angiogenic molecular target and uses thereof

Country Status (3)

Country Link
AU (1) AU2003300656A1 (en)
FR (1) FR2849055A1 (en)
WO (1) WO2004056991A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005092923A2 (en) * 2004-03-18 2005-10-06 THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICEOffice of the Technology Transfer, NIH 6011 Executive Boulevard Cytonectin and gene inhibitors thereof
CN100493609C (en) * 2005-01-19 2009-06-03 中国医学科学院基础医学研究所 Medicine composition for treating malignant tumours and application

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH686761A5 (en) * 1993-05-27 1996-06-28 Sandoz Ag Pharmaceutical formulations.
US5989860A (en) * 1997-12-12 1999-11-23 Incyte Pharmaceuticals, Inc. Human isomerase homologs
AU2103399A (en) * 1998-01-09 1999-07-26 Human Genome Sciences, Inc. Human fk506 binding proteins
AU1181900A (en) * 1998-11-17 2000-06-05 Protegene Inc. Human proteins having hydrophobic domains and dnas encoding these proteins
US20030186332A1 (en) * 2000-03-31 2003-10-02 Cristina Mitsumori Neurotrophic factor expression-inducing agent
US6687428B2 (en) * 2000-09-21 2004-02-03 Tera Op (Usa) Inc. Optical switch

Also Published As

Publication number Publication date
AU2003300656A8 (en) 2004-07-14
WO2004056991A3 (en) 2004-08-26
WO2004056991A2 (en) 2004-07-08
FR2849055A1 (en) 2004-06-25

Similar Documents

Publication Publication Date Title
AU2003270341A1 (en) Modified asialo-interferons and uses thereof
AU2002315389A1 (en) Novel pyrazolo-and pyrrolo-pyrimidines and uses thereof
AU2002311794A1 (en) Modular molecular clasps and uses thereof
AU2003233887A1 (en) Polymers their preparation and uses
AU2002315388A1 (en) Novel phenylamino-pyrimidines and uses thereof
AU2003223244A1 (en) Molecular switches and methods for making and using the same
AU2002339017A1 (en) Novel molecular target for neurotoxicity
AU2003299640A1 (en) Molecular speed and direction selection
AU2003265231A1 (en) Molecular actuators, and methods of use thereof
AU2003271183A1 (en) Block copolymer and application thereof
AU2003205381A1 (en) Hpma-polyamine conjugates and uses therefore
AU2003299943A1 (en) Heterocycles and uses thereof
AUPS110302A0 (en) Novel chalcone derivatives and uses thereof
AU2003214625A1 (en) Histone conjugates and uses thereof
AU2003248957A1 (en) Feruloyl esterase and uses thereof
AU2003231827A1 (en) Pseudo-tissues and uses thereof
AU2003296133A1 (en) Functional molecular element and functional molecular device
AU2003298739A1 (en) Intermedin and its uses
AU2003207628A1 (en) Structural and cytoskeleton-associated proteins
AU2003300656A1 (en) Novel angiogenic molecular target and uses thereof
AU2003302173A1 (en) Spirotetrathiocarbamates and spirooxothiocarbamates
AU2003235768A1 (en) Molecular trichogram
AU2003228397A1 (en) HAUSP-p53 INTERACTION AND USES THEREOF
AU2003291426A1 (en) Gp64-pseudotyped vectors and uses thereof
AUPS243002A0 (en) Therapeutic target and uses thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase